https://www.live-feeds.com/feed/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big-pharma-s-china-licensing-dealsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big-pharma-s-china-licensing-dealshttps://www.live-feeds.com/feed/treasury-sweeps-biotech-into-proposed-coins-act-restrictions-but-spares-big-pharma-s-china-licensing-deals#u158098Tue, 27 Oct 2026 12:15:54 +0000The US Department of the Treasury issued a notice of proposed rulemaking to implement the Comprehensive Outbound Investment National Security Act, sweeping biotechnology into proposed restrictions on high-tech investments involving China and other countries of concern. While the proposed rules target sensitive Chinese tech sectors including biotech and artificial intelligence, they notably leave major pharmaceutical licensing deals untouched. This regulatory action leaves investors guessing about how cross-border licensing and joint venture arrangements will be treated going forward, even as C